We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$9.62M
Cap. Flow
+$2.42M
Cap. Flow %
1.74%
Top 10 Hldgs %
27.84%
Holding
157
New
14
Increased
39
Reduced
52
Closed
19

Top Buys

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.49M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.34M
3
GM
GEN MOTORS CORP
GM
+$2.05M
4
PCYC
PHARMACYCLICS INC
PCYC
+$1.37M
5
META icon
Meta Platforms (Facebook)
META
+$1.07M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$1.98M
2
HHH icon
Howard Hughes
HHH
+$1.7M
3
DNY
DONNELLEY R R & SONS CO
DNY
+$1.39M
4
NEM icon
Newmont
NEM
+$860K
5
GLW icon
Corning
GLW
+$834K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.67%
2 Energy 14.21%
3 Technology 10.78%
4 Healthcare 9.81%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
51
Coca-Cola
KO
$383B
$830K 0.6%
21,900
+15,900
+265% +$629K
DD
52
DELISTED
Du Pont De Nemours E I
DD
$789K 0.57%
14,189
-369
-3% -$20.2K
TEX icon
53
Terex
TEX
$7.38B
$780K 0.56%
23,200
-200
-0.9% -$6.06K
COP icon
54
ConocoPhillips
COP
$156B
$775K 0.56%
11,150
+400
+4% +$26.7K
SSW.PRD
55
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
$767K 0.55%
30,400
+200
+0.7% +$5.13K
REM icon
56
iShares Mortgage Real Estate ETF
REM
$539M
$763K 0.55%
15,900
+2,500
+19% +$122K
TPR icon
57
Tapestry
TPR
$24.6B
$758K 0.54%
13,900
+900
+7% +$49.6K
DOC icon
58
Healthpeak Properties
DOC
$14.6B
$735K 0.53%
19,709
+110
+0.6% +$4.29K
STWD icon
59
Starwood Property Trust
STWD
$5.9B
$716K 0.51%
37,020
-1,054
-3% -$21.2K
OEF icon
60
iShares S&P 100 ETF
OEF
$20.5B
$709K 0.51%
9,480
-6,700
-41% -$504K
VNOD.CL
61
DELISTED
VORNADO REALTY LP 7.875% PUB INCOME NTS DUE 10/01/2039
VNOD.CL
$687K 0.49%
26,185
-200
-0.8% -$5.27K
BHC icon
62
Bausch Health
BHC
$2.36B
$678K 0.49%
+6,500
New +$633K
NLY icon
63
Annaly Capital Management
NLY
$17.4B
$677K 0.49%
14,625
-75
-0.5% -$3.53K
MET.PRA icon
64
MetLife Inc Floating Rate Series A
MET.PRA
$507M
$674K 0.48%
29,300
-1,000
-3% -$23.9K
GALT icon
65
Galectin Therapeutics
GALT
$418M
$653K 0.47%
65,500
+45,500
+228% +$307K
VALE icon
66
Vale
VALE
$65.2B
$612K 0.44%
39,200
-2,000
-5% -$29.6K
DPO
67
DELISTED
DOW ENHANCED PREMIUM & INCOME FUND, INC COM
DPO
$601K 0.43%
51,100
+1,000
+2% +$12.2K
VTNR
68
DELISTED
Vertex Energy, Inc
VTNR
$591K 0.42%
195,669
– –
AGIG
69
Abundia Global Impact Group
AGIG
$42.8M
$588K 0.42%
16,219
-64
-0.4% -$2.44K
PBA icon
70
Pembina Pipeline
PBA
$28.1B
$577K 0.41%
17,400
– –
MCR
71
DELISTED
MFS Charter Income Trust
MCR
$575K 0.41%
64,300
– –
MT icon
72
ArcelorMittal
MT
$56.3B
$554K 0.4%
17,712
– –
AIG icon
73
American International
AIG
$40.1B
$535K 0.38%
11,000
– –
ROIC
74
DELISTED
Retail Opportunity Investments Corp.
ROIC
$517K 0.37%
37,500
– –
MS.PRA icon
75
Morgan Stanley Series A Preferred Stock
MS.PRA
$756M
$515K 0.37%
26,360
– –
1 2
3
4 5

Similar funds

OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Benchmark Capital Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Benchmark Capital Advisors held 157 positions worth $139M, up 7.4% from $130M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Benchmark Capital Advisors's Q3 2013 filing shows 14 new, 39 increased, 52 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 53,400 shares worth $2.47M. The largest sale was Ligand Pharmaceuticals, an estimated $1.98M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 24% a quarter earlier, followed by Energy and Technology.

  • Benchmark Capital Advisors's largest Q3 2013 buy was Bristol-Myers Squibb: 53,400 shares worth $2.47M.
  • Benchmark Capital Advisors added most to Vodafone in Q3 2013, an estimated $2.49M increase.
  • Benchmark Capital Advisors's biggest Q3 2013 reduction was Howard Hughes, cutting an estimated $1.7M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $1.98M.
  • Benchmark Capital Advisors's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
  • Benchmark Capital Advisors opened 14 new positions and closed 19 in Q3 2013.
  • Benchmark Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $139M.

Based on Benchmark Capital Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.